BioArctic AB (publ) (STO:BIOA.B)
201.20
+1.00 (0.50%)
Jun 5, 2025, 5:29 PM CET
BioArctic AB Employees
BioArctic AB had 107 employees as of December 31, 2024. The number of employees increased by 19 or 21.59% compared to the previous year.
Employees
107
Change (1Y)
19
Growth (1Y)
21.59%
Revenue / Employee
13.08M SEK
Profits / Employee
7.78M SEK
Market Cap
17.81B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Swedish Orphan Biovitrum AB | 1,806 |
Sectra AB | 1,204 |
Getinge AB | 11,791 |
Asker Healthcare Group AB | 4,030 |
Camurus AB | 256 |
Medicover AB | 47,256 |
AddLife AB | 2,181 |
Vimian Group AB | 1,200 |
BioArctic AB News
- 5 days ago - BioArctic's Capital Markets Day 2025 - entering a new era of growth - PRNewsWire
- 23 days ago - Eisai projects Leqembi® revenue to total JPY 76.5 billion for fiscal year 2025 (April 2025 - March 2026) - PRNewsWire
- 25 days ago - Invitation to presentation of BioArctic's first quarter report for January - March 2025 on May 21 at 9.30 a.m. CET - PRNewsWire
- 4 weeks ago - Exidavnemab phase 2a study expanded to include MSA patients - PRNewsWire
- 2 months ago - The European Commission refers lecanemab decision to Appeal Committee - PRNewsWire
- 2 months ago - BioArctic's partner Eisai presents sales simulation for Leqembi® at its annual press conference - PRNewsWire
- 2 months ago - BioArctic receives Orphan Drug Designation for exidavnemab the US - PRNewsWire
- 3 months ago - Therapeutic Goods Administration decides not to register lecanemab in Australia - PRNewsWire